Wall Street trims gains after report on coronavirus drug trial [Reuters]
Las Vegas Sands Corp. (LVS)
Last las vegas sands corp. earnings: 4/22 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.sands.com/ir-home/default.aspx
Company Research
Source: Reuters
Wall Street trims gains after report on coronavirus drug trial (Reuters) - Wall Street was in positive territory on Tuesday but surrendered strong earlier gains after a report that an experimental antiviral drug for the coronavirus flopped in its first randomized clinical trial. All three main U.S. stock indexes trimmed increases of over 1%, with the S&P 500 and Nasdaq briefly turning negative after the Financial Times reported that a Chinese trial showed that Gilead Science’s ( GILD.O ) remdesivir did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream. Gilead said the results from the study were inconclusive as it was terminated early. Last Friday, Wall Street rallied in part because of a report that COVID-19 patients in a separate study had responded positively to remdesivir. The market’s sensitivity to news related to coronavirus therapies reflects investors’ desperation for any indication of when the global economy might be able to start returni
Show less
Read more
Impact Snapshot
Event Time:
LVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LVS alerts
High impacting Las Vegas Sands Corp. news events
Weekly update
A roundup of the hottest topics
LVS
News
- Las Vegas Sands (NYSE:LVS) had its price target raised by analysts at Wells Fargo & Company from $66.00 to $67.00. They now have an "equal weight" rating on the stock.MarketBeat
- Las Vegas Sands (NYSE:LVS) was given a new $67.00 price target on by analysts at Morgan Stanley.MarketBeat
- Las Vegas Sands: Fairly Valued, Healthy Outlook Ahead [Seeking Alpha]Seeking Alpha
- Las Vegas Sands (NYSE:LVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Las Vegas Sands (NYSE:LVS) had its price target lowered by analysts at Seaport Global Securities from $75.00 to $72.00. They now have a "buy" rating on the stock.MarketBeat
LVS
Earnings
- 10/22/25 - Beat
LVS
Sec Filings
- 12/18/25 - Form 4
- 12/18/25 - Form 4
- 12/18/25 - Form SCHEDULE
- LVS's page on the SEC website